Aborted myocardial infarction in patients with ST-segment elevation myocardial infarction treated with mechanical

Kardiologia Polska
|October 20, 2020
PubMed

Insights

Aborted myocardial infarction (abMI) patients treated with primary percutaneous coronary intervention (pPCI) show better outcomes. This study defines abMI and identifies characteristics of these patients, including younger age and higher ejection fraction.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Aborted myocardial infarction (abMI) is a subset of acute coronary syndrome where necrosis is avoided post-reperfusion.
  • No standardized definition for abMI in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI) exists.

Purpose of the Study:

  • To establish a definition for abMI in STEMI patients treated with pPCI.
  • To compare the clinical characteristics and outcomes of abMI patients with other STEMI patients.

Main Methods:

  • Retrospective analysis of 1693 STEMI patients treated with pPCI.
  • AbMI definition criteria: >50% ST-segment elevation reduction, no new Q waves, peak CK-MB <5x upper limit of normal, and Thrombolysis in Myocardial Infarction (TIMI) score of 3 post-PCI.
  • Median follow-up of 3.45 years.

Main Results:

  • AbMI identified in 10.4% of patients (176 cases).
  • AbMI patients were younger, more frequent smokers, had higher left ventricular ejection fraction, shorter hospitalization, and significantly lower 1-month and long-term mortality.
  • Key differences observed: age (61.8 vs 64.4 years), smoking (48.9% vs 36.7%), LVEF (49% vs 55%), hospitalization (73 vs 87 hours), mortality (2.27% vs 8% at 1 month; 10.8% vs 23.9% long-term).

Conclusions:

  • A clear definition for abMI in pPCI-treated STEMI patients was established.
  • Patients with abMI demonstrate superior short- and long-term clinical outcomes compared to other STEMI patients.
  • Despite presenting with risk factors like smoking, abMI patients experience better prognoses, highlighting the effectiveness of timely reperfusion therapy.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
451
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
128
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
93